Cargando…
Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial
STUDY QUESTION: Are progesterone vaginal pessaries 400 mg twice a day (bid) non-inferior to progesterone vaginal gel (90 mg) once a day (od) in the primary endpoint of clinical pregnancy rate after 38 days of luteal phase support in women undergoing in vitro fertilisation (IVF)? SUMMARY ANSWER: Non-...
Autores principales: | Saunders, Helen, Khan, Cass, D’Hooghe, Thomas, Magnúsdóttir, Thora Björg, Klingmann, Ingrid, Hrafnsdóttir, Sigrún |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048710/ https://www.ncbi.nlm.nih.gov/pubmed/32074281 http://dx.doi.org/10.1093/humrep/dez261 |
Ejemplares similares
-
Progesterone for Luteal Phase Support in In Vitro Fertilization: Comparison of Vaginal and Rectal Pessaries to Vaginal Capsules: A Randomized Controlled Study
por: Khrouf, Mohamed, et al.
Publicado: (2017) -
Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes
por: Jabara, Sami, et al.
Publicado: (2009) -
A randomised control trial on oral dydrogesterone versus micronized vaginal progesterone pessary for luteal phase support in in vitro fertilization cycles
por: Ikechebelu, Joseph Ifeanyichukwu, et al.
Publicado: (2023) -
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014) -
Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
por: Zareii, Afsoon, et al.
Publicado: (2021)